文献速递关节外科

中枢敏化与神经病理性疼痛对全膝关节置换术后患者报告较差结局的累积影响

Central Sensitization and Neuropathic Pain Cumulatively Affect Patients Reporting Inferior Outcomes Following Total Knee Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2023-11-09

研究纳入316例因终末期膝骨关节炎行初次单侧全膝关节置换术的亚洲(韩国)患者,按中枢敏化(中枢敏化量表≥40分)和神经病理性疼痛(painDETECT问卷≥19分)分为4组,比较术前和术后2年的WOMAC评分。结果显示两种状况均与较差的患者报告结局相关,且同时存在两者时结局更差。

要点

  • 316例患者中17.4%同时存在中枢敏化和神经病理性疼痛,21.5%仅有中枢敏化,11.1%仅有神经病理性疼痛,50.0%两者均无。
  • 术前Groups 1、2、3的WOMAC疼痛、功能和总分均显著劣于Group 4(p < 0.05 for all)。
  • 术后2年Group 1的WOMAC疼痛、功能和总分劣于其他各组(p < 0.05 for all),Groups 2和3劣于Group 4(p < 0.05 for all)。

核心结论

  • 中枢敏化和神经病理性疼痛各自与全膝关节置换术后较差的患者报告结局相关。
  • 同时存在中枢敏化和神经病理性疼痛的患者较仅有其中一种或均无的患者报告更差的结局。

研究设计与样本

  • 纳入316例因终末期膝骨关节炎行初次单侧全膝关节置换术的患者。
  • 中枢敏化定义为中枢敏化量表评分≥40分,神经病理性疼痛定义为painDETECT问卷评分≥19分。
  • 按是否存在中枢敏化和神经病理性疼痛分为4组:Group 1两者均有,Group 2仅有中枢敏化,Group 3仅有神经病理性疼痛,Group 4两者均无。
  • 术前和术后2年采用WOMAC评分评估患者报告结局,比较各组间差异。
  • 所有参与者均为亚洲人,尤其是韩国人。

主要发现

  • 55例(17.4%)同时有中枢敏化和神经病理性疼痛,68例(21.5%)仅有中枢敏化,35例(11.1%)仅有神经病理性疼痛,158例(50.0%)两者均无。
  • 所有WOMAC子评分在术前和术后4组间均显示显著差异(p < 0.05 for all)。
  • 术前事后分析中,Groups 1、2、3的WOMAC疼痛、功能和总分均显著劣于Group 4(p < 0.05 for all)。
  • 术后2年,Group 1的WOMAC疼痛、功能和总分劣于其他各组(p < 0.05 for all);Groups 2和3的WOMAC疼痛、功能和总分劣于Group 4(p < 0.05 for all)。

关键数值与推荐

  • 中枢敏化:中枢敏化量表评分≥40分。
  • 神经病理性疼痛:painDETECT问卷评分≥19分。
  • 患者报告结局评估工具:WOMAC评分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article was updated on November 17, 2023, because of previous errors, which were discovered after the preliminary version of the article was posted online. On page 102, the text that had read "In a post hoc analysis of the preoperative results, Group 1 showed significantly inferior WOMAC pain, function, and total scores compared with Group 4 (p < 0.05 for all). Groups 2 and 3 showed worse preoperative WOMAC pain, function, and total subscores compared with Group 4 (p < 0.05 for all). These results remained the same at 2 years after surgery." now reads "In a post hoc analysis of the preoperative results, Groups 1, 2, and 3 showed significantly inferior WOMAC pain, function, and total scores compared with Group 4 (p < 0.05 for all). At 2 years postoperatively, Group 1 showed inferior WOMAC pain, function, and total scores compared with the other groups (p < 0.05 for all). Also, Groups 2 and 3 had worse WOMAC pain, function and total scores compared with Group 4 (p < 0.05 for all)." Also, on page 106, the title of Table IV, which had previously read "Inter-Group Comparison of Preoperative Scores (Post Hoc Analysis)" now reads "Inter-Group Comparison of Postoperative Scores (Post Hoc Analysis)." Available studies on the relationship between central sensitization and neuropathic pain, and on their association with patient-reported outcome measures (PROMs), following total knee arthroplasty (TKA) are insufficient. The purpose of the present study was to investigate this association. A total of 316 patients who underwent primary unilateral TKA for the treatment of end-stage osteoarthritis (OA) of the knee were enrolled. Central sensitization was defined as a score of ≥40 on the Central Sensitization Inventory. Neuropathic pain was defined as a score of ≥19 on the painDETECT Questionnaire (PDQ). PROMs were also evaluated on the basis of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score preoperatively and at 2 years postoperatively. The patients were divided into 4 groups: Group 1 had both central sensitization and neuropathic pain, Group 2 had central sensitization only, Group 3 had neuropathic pain only, and Group 4 had neither central sensitization nor neuropathic pain. Preoperative and postoperative PROMs were compared among the groups. All individuals who participated in the study were Asian, especially Korean. Fifty-five patients (17.4%) had both central sensitization and neuropathic pain, 68 (21.5%) had central sensitization only, 35 (11.1%) had neuropathic pain only, and 158 (50.0%) had neither condition. All WOMAC subscores showed significant differences among the 4 groups before and after surgery (p < 0.05 for all). In a post hoc analysis of the preoperative results, Groups 1, 2, and 3 showed significantly inferior WOMAC pain, function, and total scores compared with Group 4 (p < 0.05 for all). At 2 years postoperatively, Group 1 showed inferior WOMAC pain, function, and total scores compared with the other groups (p < 0.05 for all). Also, Groups 2 and 3 had worse WOMAC pain, function and total scores compared with Group 4 (p < 0.05 for all). Each condition, central sensitization and neuropathic pain, was associated with inferior PROMs following TKA. Furthermore, patients with both central sensitization and neuropathic pain showed worse PROMs compared with patients with either condition alone or without either condition. Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Kim MS, Kim JJ, Kang KH, et al. Central Sensitization and Neuropathic Pain Cumulatively Affect Patients Reporting Inferior Outcomes Following Total Knee Arthroplasty. J Bone Joint Surg Am. 2023. PMID: 37943951. doi:10.2106/JBJS.23.00399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。